Effects of GLP-1 Analogs on Cardiovascular Health
Dr. Richard Shannon, University of Pennsylvania, during the VBWG meeting at AHA in LA, recognizes that Diabetes is a CVD equivalent and focuses on the importance that incretins can play in improving hemodynamics and outcomes in Heart Failure.
Share this page with your colleagues and friends: